AEZS One Step Closer, AKTX To Report Data In April, CBIO On The Move

Aeterna Zentaris Inc. is gearing up to file a new drug application seeking approval of Macrilen for the evaluation of growth hormone deficiency in adults in the third quarter of this year.

from RTT - Biotech http://ift.tt/2ohH9VG
via IFTTT